Skip to main content
  • Back
    About us
    • Purpose and Strategy
    • Corporate Governance
      • Board of Directors
      • Executive Committee
    • Environmental, Social and Governance
      • Our Business model
      • Our four commitments
      • Non financial key figures
      • ESG Certifications and Performance
      • Resource center
    • Business Ethics and Compliance
      • Nos principes éthiques
      • Our ethical principles
      • Supplier corner
      • Whistleblowing System

    About us

    At EUROAPI, we’re reinventing active ingredient solutions to meet customers’ and patients’ needs around the world in a sustainable way.

  • Back
    API Solutions
    • API List
    • Vitamin B12
    • Prostaglandins
    • Corticoids & Hormones
    • Anti Infectives
    • Opiates & Controlled Substances
    • Small and Complex Molecules
    • Products under development
    • Intermediates and Reagents List

    API Solutions

    Euroapi offers the largest portfolio of APIs in the world, counting upwards of 200 ingredients, addressing a wide population of patients and providing global coverage for more than 80 countries.

  • Back
    CDMO services
    • Tides | CDMO
      • Oligonucleotides
    • Small Molecules Synthesis | CDMO
    • Lipids | CDMO
    • Particle Engineering | CDMO
      • Micronization capability
      • Spray drying capability
    • Microbial Fermentation | CDMO
      • Enzymes
    • Prostaglandins | CDMO
    • Steroids and Hormones | CDMO

    CDMO services

  • Industrial Footprint
    Back
    Industrial Footprint

    Industrial Footprint

  • Careers
    Back
    Careers

    Careers

  • Back
    Investors
    • Publications and Events
      • Calendar
      • Results
      • Press releases
      • Investor presentations
    • Stock information
      • Share data
      • Shareholding structure
      • Dividend
      • Becoming a shareholder
    • Share coverage
      • Analyst coverage
      • Consensus
    • Regulatory information
      • Press releases
      • Annual General Meetings
      • Financial reports
      • Voting rights and shares
      • Liquidity Contract
      • Other legal and corporate documents
    • Corporate Governance
      • Board of Directors
      • Executive Committee
      • Other documents
      • Business Ethics and Compliance
    • Environmental, Social and Governance
      • Our Business model
      • Our four commitments
      • Non financial key figures
      • ESG Certifications and Performance
      • Resource center

    Investors

    You are an investor, an analyst or an individual shareholder and have a question about EUROAPI, please contact the Investor Relations department.

    The role of the Investor Relations department is to maintain a transparent and comprehensive dialogue with the financial community about EUROAPI's strategy, outlook and financial data, its economic environment and any other useful information.

     

    Sophie Palliez

    Head of Investor Relations
    ir@euroapi.com

  • Back
    Media
    • Press Releases
    • News
    • Events
    • Images
      • Board of Directors
      • Executive Committee
      • Sites
      • Equipments
    • Subscribe

    Media

    You are a journalist and have a question about Euroapi, please contact the Global Media Relations department.

    Laurence Bollack, Head of Global Media Relations
    +33 (0)6 81 86 80 19 • mr@euroapi.com

    Please note the contact details are only for journalists.

  • Partner with us
    Back
    Partner with us

    Partner with us

  • Back
    About us
    • Purpose and Strategy
    • Corporate Governance
      • Board of Directors
      • Executive Committee
    • Environmental, Social and Governance
      • Our Business model
      • Our four commitments
      • Non financial key figures
      • ESG Certifications and Performance
      • Resource center
    • Business Ethics and Compliance
      • Nos principes éthiques
      • Our ethical principles
      • Supplier corner
      • Whistleblowing System

    About us

    At EUROAPI, we’re reinventing active ingredient solutions to meet customers’ and patients’ needs around the world in a sustainable way.

  • Back
    API Solutions
    • API List
    • Vitamin B12
    • Prostaglandins
    • Corticoids & Hormones
    • Anti Infectives
    • Opiates & Controlled Substances
    • Small and Complex Molecules
    • Products under development
    • Intermediates and Reagents List

    API Solutions

    Euroapi offers the largest portfolio of APIs in the world, counting upwards of 200 ingredients, addressing a wide population of patients and providing global coverage for more than 80 countries.

  • Back
    CDMO services
    • Tides | CDMO
      • Oligonucleotides
    • Small Molecules Synthesis | CDMO
    • Lipids | CDMO
    • Particle Engineering | CDMO
      • Micronization capability
      • Spray drying capability
    • Microbial Fermentation | CDMO
      • Enzymes
    • Prostaglandins | CDMO
    • Steroids and Hormones | CDMO

    CDMO services

  • Industrial Footprint
    Back
    Industrial Footprint

    Industrial Footprint

  • Careers
    Back
    Careers

    Careers

  • Back
    Investors
    • Publications and Events
      • Calendar
      • Results
      • Press releases
      • Investor presentations
    • Stock information
      • Share data
      • Shareholding structure
      • Dividend
      • Becoming a shareholder
    • Share coverage
      • Analyst coverage
      • Consensus
    • Regulatory information
      • Press releases
      • Annual General Meetings
      • Financial reports
      • Voting rights and shares
      • Liquidity Contract
      • Other legal and corporate documents
    • Corporate Governance
      • Board of Directors
      • Executive Committee
      • Other documents
      • Business Ethics and Compliance
    • Environmental, Social and Governance
      • Our Business model
      • Our four commitments
      • Non financial key figures
      • ESG Certifications and Performance
      • Resource center

    Investors

    You are an investor, an analyst or an individual shareholder and have a question about EUROAPI, please contact the Investor Relations department.

    The role of the Investor Relations department is to maintain a transparent and comprehensive dialogue with the financial community about EUROAPI's strategy, outlook and financial data, its economic environment and any other useful information.

     

    Sophie Palliez

    Head of Investor Relations
    ir@euroapi.com

  • Back
    Media
    • Press Releases
    • News
    • Events
    • Images
      • Board of Directors
      • Executive Committee
      • Sites
      • Equipments
    • Subscribe

    Media

    You are a journalist and have a question about Euroapi, please contact the Global Media Relations department.

    Laurence Bollack, Head of Global Media Relations
    +33 (0)6 81 86 80 19 • mr@euroapi.com

    Please note the contact details are only for journalists.

  • Partner with us
    Back
    Partner with us

    Partner with us

  • en
  • fr
  • hu
  • it
  • de
  • EN
  • FR
Breadcrumb
  1. Home
  2. About Us
  3. Financial Calendar | Upcoming and Past Events
  4. Annual General Meeting
Breadcrumb
  1. Home
  2. About Us
  3. Financial Calendar | Upcoming and Past Events
  4. Annual General Meeting

Annual General Meeting

Stroke 10 May 11, 2023

3 RUE MAZARINE
75006 PARIS
France

11 MAY
02:30 PM CET
3 MAZARIUM, 3 RUE MAZARINE 75006 PARIS

Access all information

Back

Partner with us

Contact
A girl smiling at another woman in a field
LinkedIn
  • Sitemap
  • Legal notice
  • Data policy
  • Accessibility
  • Cookies Policy
  • Terms and Conditions
© 2024 EUROAPI